减重手术ERAS方案:术后第1天出院安全吗?
该单中心回顾性研究纳入214例腹腔镜袖状胃切除术患者,比较ERAS方案与标准护理的临床结局。ERAS组中位住院时间显著更短(1天 vs 2天,p<0.001),7天和30天再入院率及并发症率无差异,结论认为ERAS方案可缩短住院时间而不增加围术期并发症或再入院风险。
要点
- ERAS方案使腹腔镜袖状胃切除术中位住院时间从2天缩短至1天。
- ERAS组7天和30天再入院率及并发症率与标准护理组无显著差异。
- ERAS组术后第1天疼痛评分和术中阿片类药物消耗中位数更低。
核心结论
- 腹腔镜袖状胃切除术的ERAS方案可缩短住院时间,且不增加围术期并发症或再入院率。
主要发现
- ERAS组中位住院时间显著短于标准护理组(1天 vs 2天,p<0.001)。
- 7天再入院率ERAS组1.5% vs 标准组1.2%(p=0.838),30天再入院率2.3% vs 2.4%(p=0.966),均无显著差异。
- 术后并发症率ERAS组6.2% vs 标准组3.6%(p=0.410),无显著差异。
- ERAS组术中阿片类药物消耗中位数(27.5 MME vs 27.4 MME,p=0.044)和术后第1天自报疼痛评分(3.3 vs 3.9,p=0.046)更低。
- 总体死亡率为0%。
关键数值与推荐
- ERAS方案包括目标导向的患者教育、特定的术前和术后多模式用药方案、早期下床活动和早期经口进食。
- 患者达到适当的术后里程碑后于术后第1天出院。
临床怎么用
- 对于腹腔镜袖状胃切除术患者,可实施包含患者教育、多模式用药、早期活动与早期进食的ERAS方案。
- 达到术后里程碑的患者可考虑术后第1天出院,不增加再入院或并发症风险。
局限性
- 单中心回顾性研究,样本量有限,非随机分组,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic sleeve gastrectomy is the most commonly performed bariatric surgery in the world. Enhanced recovery after surgery (ERAS) protocols have been shown to reduce complications and decrease length of stay for various types of surgeries. In this study, we propose an ERAS protocol for laparoscopic sleeve gastrectomy and compare the clinical outcomes with patients who received standard care. METHODS: We performed a single-institution retrospective analysis in patients who underwent laparoscopic sleeve gastrectomy from February 2015 to December 2017. Patients were stratified into standard care and ERAS protocol groups. The ERAS protocol consisted of goal-directed patient education, specific pre- and post-op multi-modal medication regimen, early ambulation, and early oral intake. Patients were discharged on their first post-operative day if they met appropriate post-surgical milestones. The primary outcomes were length of stay, 7- and 30-day readmission rates, and complication rates. Secondary outcomes included anti-emetic and pain medication utilization, post-operative emesis episodes per day, post-operative pain scores, and mortality. RESULTS: We included 214 consecutive patients who underwent sleeve gastrectomy, 130 were in the ERAS group and 84 were in the standard care group. Median hospital stay was significantly shorter in the ERAS group compared to the standard care group (1 vs. 2 days; p < 0.001). There were no differences in 7- or 30-day readmission rates (1.5 vs. 1.2%; p = 0.838, 2.3 vs. 2.4%; p = 0.966) or post-operative complications (6.2 vs. 3.6%; p = 0.410). The ERAS group also had decreased median intra-operative opioid consumption and self-reported pain scores on post-operative day 1 (27.5 MME vs. 27.4 MME; p = 0.044, 3.3 vs. 3.9; p = 0.046). Mortality rate was 0% overall. CONCLUSION: A cost-effective ERAS protocol for laparoscopic sleeve gastrectomy results in shorter length of stay, without increase in peri-operative morbidity or readmission rates.
引用
- Lam J, Suzuki T, Bernstein D, et al. An ERAS protocol for bariatric surgery: is it safe to discharge on post-operative day 1? Surg Endosc. 2018. PMID: 30120584. doi:10.1007/s00464-018-6368-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。